C07C 237/30
Having the nitrogen atom of the carboxamide group bound to hydrogen atoms
Official title: having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
C07C237/30 (Having the nitrogen atom of the carboxamide group bound to hydrogen atoms) appears on 270 US grants and 251 published applications in this corpus.
Search patents in C07C- Granted patents
- 270
- Published applications
- 251
- Assignees
- 198
- Inventors
- 921
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 5 | 0 |
| 1997 | 8 | 0 |
| 1998 | 14 | 0 |
| 1999 | 9 | 0 |
| 2000 | 9 | 0 |
| 2001 | 12 | 4 |
| 2002 | 23 | 11 |
| 2003 | 11 | 27 |
| 2004 | 23 | 15 |
| 2005 | 8 | 20 |
| 2006 | 10 | 8 |
| 2007 | 15 | 18 |
| 2008 | 3 | 12 |
| 2009 | 10 | 5 |
| 2010 | 7 | 11 |
| 2011 | 9 | 8 |
| 2012 | 3 | 8 |
| 2013 | 7 | 4 |
| 2014 | 6 | 11 |
| 2015 | 6 | 14 |
| 2016 | 8 | 15 |
| 2017 | 10 | 9 |
| 2018 | 14 | 8 |
| 2019 | 9 | 12 |
| 2020 | 4 | 2 |
| 2021 | 3 | 7 |
| 2022 | 4 | 5 |
| 2023 | 1 | 6 |
| 2024 | 1 | 4 |
| 2025 | 2 | 2 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Chlorantraniliprole process through use of a crystal intermediate22 Sep 2026US 12,741,951 B2FMC Corporation
- Small molecules targeting the intrinsically disordered structural ensemble of α-synuclein protect against diverse α-synuclein mediated dysfunctions17 Feb 2026US 12,553,889 B2Dainton Biosciences, LLC
- Methods and materials for increasing level of phosphorylated AMPK protein30 Sep 2025US 12,428,378 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Modulators of sestrin-GATOR2 interaction and uses thereof5 Aug 2025US 12,378,263 B2Navitor Pharmaceuticals, Inc.
- Compounds useful in the treatment of disorders associated with mutant RAS30 Apr 2024US 11,970,469 B2The Institute of Cancer Research: Royal Cancer Hospital
- Tertiary amine derivatives and their uses for treating a viral infection10 Sep 2026US 2026/0265178 A1Enyo Pharma
- Compounds and methods for treating cancer18 Jun 2026US 2026/0166051 A1The Regents of the University of California
- Methods and materials for increasing level of phosphorylated ampk protein21 May 2026US 2026/0138955 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Covalent, chemogenetic activators for k2p potassium channels and uses thereof9 Apr 2026US 2026/0098008 A1The Regents of the University of California
- Modulators of sestrin-gator2 interaction and uses thereof26 Feb 2026US 2026/0055122 A1Navitor Pharmaceuticals, Inc.
Most cited
By later US patents
- Aryloxypropanolamine .beta. 3 adrenergic agonists115US 5,541,204 ABristol-Myers Squibb Company · 1996
- Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist104US 5,460,605 AGensia, Inc. · 1995
- 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors87US 6,310,060 B1Warner-Lambert Company · 2001
- Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist83US 5,286,252 AGensia Pharmaceuticals, Inc. · 1994
- Anthranilic acid derivatives78US 5,716,993 AEisai Co., Ltd. · 1998